Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

China Active Pharmaceutical Ingredients Market Report 2021

  • QYR676895
  • 100 Pages
  • August 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Active Pharmaceutical Ingredients

Revenue, means the sales value of Active Pharmaceutical Ingredients

This report studies sales (consumption) of Active Pharmaceutical Ingredients in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Teva Active Pharmaceutical Industries Limited

DSM

Novartis

Roche

Johnson?&?Johnson

Dr. Reddy’s

Pfizer

Bayer

BASF

Cambrex

Sun Pharmaceutical Industries

Lonza group

Boehringer Ingelheim GmbH

Aurobindo pharma

Lupin

Biocon

Cipla

Hisun Pharmacy

Huahai Pharmaceutical

North China Pharmaceutical Group

Shandong Lukang Pharmaceutical Co., Ltd

Haerbin Pharmaceutical Group

Shandong Xinhua Pharmaceutical Co.,Ltd

Jiangsu?Hengrui Medicine

Tian Yao

North East Pharmaceutical

Zhejiang Medicine

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

China Active Pharmaceutical Ingredients Market Report 2021

1 Active Pharmaceutical Ingredients Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients

1.2 Classification of Active Pharmaceutical Ingredients

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Applications of Active Pharmaceutical Ingredients

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 China Market Size (Value and Volume) of Active Pharmaceutical Ingredients (2011-2021)

1.4.1 China Active Pharmaceutical Ingredients Sales, Revenue and Price (2011-2021)

1.4.2 China Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

1.4.3 China Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

2 China Active Pharmaceutical Ingredients Competition by Manufacturers

2.1 China Active Pharmaceutical Ingredients Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 China Active Pharmaceutical Ingredients Revenue and Share by Manufactures (2015 and 2016)

3 China Active Pharmaceutical Ingredients (Volume and Value) by Type

3.1 China Active Pharmaceutical Ingredients Sales and Market Share by Type (2011-2021)

3.2 China Active Pharmaceutical Ingredients Revenue and Market Share by Type (2011-2021)

4 China Active Pharmaceutical Ingredients (Volume) by Application

5 China Active Pharmaceutical Ingredients Manufacturers Analysis

5.1 Teva Active Pharmaceutical Industries Limited

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Active Pharmaceutical Ingredients Product Type and Technology

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Teva Active Pharmaceutical Industries Limited (2015 and 2016)

5.2 DSM

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Pharmaceuticals Sales, Revenue, Price of DSM (2015 and 2016)

5.3 Novartis

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Novartis Product Type and Technology

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Novartis Sales, Revenue, Price of Novartis (2015 and 2016)

5.4 Roche

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 BASF Product Type and Technology

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)

5.5 Johnson?&?Johnson

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Johnson?&?Johnson Product Type and Technology

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Johnson?&?Johnson Sales, Revenue, Price of Johnson?&?Johnson (2015 and 2016)

5.6 Dr. Reddy’s

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Dr. Reddy’s Product Type and Technology

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Dr. Reddy’s Sales, Revenue, Price of Dr. Reddy’s (2015 and 2016)

5.7 Pfizer

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Pfizer Product Type and Technology

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)

5.8 Bayer

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Bayer Product Type and Technology

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bayer Sales, Revenue, Price of Bayer (2015 and 2016)

5.9 BASF

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 BASF Product Type and Technology

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 BASF Sales, Revenue, Price of BASF (2015 and 2016)

5.10 Cambrex

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Cambrex Product Type and Technology

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Cambrex Sales, Revenue, Price of Cambrex (2015 and 2016)

5.11 Sun Pharmaceutical Industries

5.12 Lonza group

5.13 Boehringer Ingelheim GmbH

5.14 Aurobindo pharma

5.15 Lupin

5.16 Biocon

5.17 Cipla

5.18 Hisun Pharmacy

5.19 Huahai Pharmaceutical

5.20 North China Pharmaceutical Group

5.21 Shandong Lukang Pharmaceutical Co., Ltd

5.22 Haerbin Pharmaceutical Group

5.23 Shandong Xinhua Pharmaceutical Co.,Ltd

5.24 Jiangsu?Hengrui Medicine

5.25 Tian Yao

5.26 North East Pharmaceutical

5.27 Zhejiang Medicine

6 Active Pharmaceutical Ingredients Technology and Development Trend

6.1 Active Pharmaceutical Ingredients Technology Analysis

6.2 Active Pharmaceutical Ingredients Technology Development Trend

7 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredients

Table Classification of Active Pharmaceutical Ingredients

Figure China Sales Market Share of Active Pharmaceutical Ingredients by Type in 2015

Table Applications of Active Pharmaceutical Ingredients

Figure China Sales Market Share of Active Pharmaceutical Ingredients by Application in 2015

Table China Active Pharmaceutical Ingredients Sales, Revenue and Price (2011-2021)

Figure China Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure China Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Table China Active Pharmaceutical Ingredients Sales of Key Manufacturers (2015 and 2016)

Table China Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Active Pharmaceutical Ingredients Sales Share by Manufacturers

Figure 2016 Active Pharmaceutical Ingredients Sales Share by Manufacturers

Table China Active Pharmaceutical Ingredients Revenue by Manufacturers (2015 and 2016)

Table China Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Active Pharmaceutical Ingredients Revenue Share by Manufacturers

Table 2016 China Active Pharmaceutical Ingredients Revenue Share by Manufacturers

Table China Active Pharmaceutical Ingredients Sales and Market Share by Type (2011-2021)

Table China Active Pharmaceutical Ingredients Sales Share by Type (2011-2021)

Figure Sales Market Share of Active Pharmaceutical Ingredients by Type (2011-2021)

Figure China Active Pharmaceutical Ingredients Sales Growth Rate by Type (2011-2021)

Table China Active Pharmaceutical Ingredients Revenue and Market Share by Type (2011-2021)

Table China Active Pharmaceutical Ingredients Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type (2011-2021)

Figure China Active Pharmaceutical Ingredients Revenue Growth Rate by Type (2011-2021)

Table China Active Pharmaceutical Ingredients Sales and Market Share by Application (2011-2021)

Table China Active Pharmaceutical Ingredients Sales Share by Application (2011-2021)

Figure Sales Market Share of Active Pharmaceutical Ingredients by Application (2011-2021)

Figure China Active Pharmaceutical Ingredients Sales Growth Rate by Application (2011-2021)

Table Teva Active Pharmaceutical Industries Limited Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Teva Active Pharmaceutical Industries Limited (2015 and 2016)

Table DSM Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of DSM (2015 and 2016)

Table Novartis Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Novartis (2015 and 2016)

Table Roche Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Roche (2015 and 2016)

Table Johnson?&?Johnson Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Johnson?&?Johnson (2015 and 2016)

Table Dr. Reddy’s Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Dr. Reddy’s (2015 and 2016)

Table Pfizer Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Bayer Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Bayer (2015 and 2016)

Table BASF Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of BASF (2015 and 2016)

Table Cambrex Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Cambrex (2015 and 2016)

Table Sun Pharmaceutical Industries Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Sun Pharmaceutical Industries (2015 and 2016)

Table Lonza group Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Lonza group (2015 and 2016)

Table Boehringer Ingelheim GmbH Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Boehringer Ingelheim GmbH (2015 and 2016)

Table Aurobindo pharma Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Aurobindo pharma (2015 and 2016)

Table Lupin Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Lupin (2015 and 2016)

Table Biocon Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Biocon (2015 and 2016)

Table Cipla Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Cipla (2015 and 2016)

Table Hisun Pharmacy Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Hisun Pharmacy (2015 and 2016)

Table Huahai Pharmaceutical Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Huahai Pharmaceutical (2015 and 2016)

Table North China Pharmaceutical Group Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of North China Pharmaceutical Group (2015 and 2016)

Table Shandong Lukang Pharmaceutical Co., Ltd Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Shandong Lukang Pharmaceutical Co., Ltd (2015 and 2016)

Table Haerbin Pharmaceutical Group Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Haerbin Pharmaceutical Group (2015 and 2016)

Table Shandong Xinhua Pharmaceutical Co.,Ltd Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Shandong Xinhua Pharmaceutical Co.,Ltd (2015 and 2016)

Table Jiangsu?Hengrui Medicine Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Jiangsu?Hengrui Medicine (2015 and 2016)

Table Tian Yao Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Tian Yao (2015 and 2016)

Table North East Pharmaceutical Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of North East Pharmaceutical (2015 and 2016)

Table Zhejiang Medicine Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Zhejiang Medicine (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370